Faropenem 300 mg (extended release or sustained release formulations) is an oral broad-spectrum antibiotic indicated for the treatment of various severe bacterial infections caused by susceptible microorganisms. It is typically used for infections that have not responded to other antibiotics. Key indications include: Respiratory Tract Infections: Both upper and lower, including community-acquired pneumonia, acute bronchitis, acute bacterial sinusitis, pharyngitis, and tonsillitis. Urinary Tract Infections (UTIs): Including complicated UTIs, cystitis, and pyelonephritis (kidney infections). Skin and Soft Tissue Infections: Such as cellulitis, abscesses, folliculitis, and infected wounds. Gynecological Infections: Including pelvic inflammatory disease and adnexitis. Ear, Nose, and Throat (ENT) Infections: Such as otitis media and tympanitis. Faropenem works by inhibiting the synthesis of the bacterial cell wall, which is essential for bacterial survival, thus killing the bacteria. It is effective against a wide range of bacteria, including some beta-lactamase-producing strains that are resistant to other antibiotics.
| FEROPENEM 300 | 1800 |